VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 33 filers reported holding VASCULAR BIOGENICS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 798 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 798 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 798 | +2651.7% | 0.00% | – |
| Q4 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 29 | +123.1% | 0.00% | – |
| Q1 2018 | $0 | – | 13 | -7.1% | 0.00% | – |
| Q4 2017 | $0 | – | 14 | +40.0% | 0.00% | – |
| Q1 2017 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |